Cancer Biology Research in Massachusetts
Cancer Biology Research (93.396) awarded $409 million to recipients in Massachusetts in 263 grants from fiscal 2021 to 2025, 9.5% of the program's national total. Dana-Farber Cancer Institute, Inc. received the most, $107 million.
- Awarded in Massachusetts$409 million
- Awards263
- Share of the program9.5%
- Rank among states3rd of 50
- National total$4.3 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 159 | $89.5 million |
| FY 2022 | 148 | $84.4 million |
| FY 2023 | 151 | $83.1 million |
| FY 2024 | 137 | $76.3 million |
| FY 2025 | 126 | $75.5 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Dana-Farber Cancer Institute, Inc. | Nonprofits | 47 | $107 million |
| The General Hospital Corporation | Nonprofits | 38 | $45.5 million |
| Brigham & Womens Hospital Inc | Nonprofits | 29 | $43.3 million |
| Beth Israel Deaconess Medical Center, Inc. | Nonprofits | 19 | $39.1 million |
| President and Fellows of Harvard College | Colleges and universities | 16 | $27.7 million |
| University of Massachusetts Medical School | Colleges and universities | 20 | $26.2 million |
| Massachusetts Institute of Technology | Colleges and universities | 14 | $22.5 million |
| The Children's Hospital Corporation | Nonprofits | 15 | $18.0 million |
| President and Fellows of Harvard College | Colleges and universities | 7 | $16.0 million |
| The Broad Institute, Inc | Nonprofits | 13 | $15.8 million |
Open opportunities under this program
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much Cancer Biology Research money goes to Massachusetts?
$409 million from fiscal 2021 to 2025, across 263 awards. Massachusetts ranks 3rd of 50 states and territories for this program.
Who receives Cancer Biology Research money in Massachusetts?
The largest recipient is Dana-Farber Cancer Institute, Inc., with $107 million in 47 awards. Next are The General Hospital Corporation and Brigham & Womens Hospital Inc.
Can organizations in Massachusetts apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Biology Research in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Allergy and Infectious Diseases Research
- Aging Research